Regentis Share Price

Regentis Share Price

AMEX: RGNT | Healthcare
$0.75
-$0.21 (-21.87%) Last updated on 21 Nov, 2026 | 01:35 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Regentis Stock Performance

Open
$0.71
Prev. Close
$0.96
Circuit Range
N/A
Day Range
$0.71 - $0.76
Year Range
$0.71 - $15.40
Volume
2,103
Average Traded
$0.75

Regentis Share Price Today

As of 21 November 2026, Regentis Biomaterials Ltd.'s share price is $0.75. The stock opened at $0.71, compared to its previous close of $0.96. During today's trading session, Regentis Biomaterials Ltd.'s share price traded between $0.71 and $0.76, with an average price of $0.74. Over the past 52 weeks, the stock has recorded a high of $15.40 and a low of $0.71. In terms of performance, Regentis Biomaterials Ltd.'s share price has declined by 65.28% over the last six months and is down 88.97% on a year-on-year basis.

Regentis Share Price Chart

Line chart of the Regentis price trend over the selected period. The price fell overall, ranging from 0.71 to 0.76, ending at 0.75.
$0.71$0.76
L
Show Current Price
H

Regentis Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$0.00
Return On Equity (TTM)
N/A
Profit Margin
N/A
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

Regentis Annual Profit & Loss

All figures in USD

Particulars2025
Revenue$0.00
Net Profit-$13.65
Net Profit MarginN/A
Income ChangeN/A

Regentis Balance Sheet

All figures in USD Million

Particulars2025
Non Current Assets0.0
Current Assets7.62
Total Assets7.62
Non Current Liabilities0.0
Current Liabilities2.87
Total Liabilities2.87
Shareholders' Equity4.74

Regentis Cash Flow

Annually
Particulars2025
Operating (USD Million)-1.38
Investing (USD Billion)0.0
Financing (USD Million)8.52

About Regentis

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Regentis Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.36
$0.75
-44.44%
Oct 2026
$1.85
$1.35
-28.95%
Sep 2026
$2.03
$1.90
-9.52%
Aug 2026
$1.73
$2.10
+20.69%
Jul 2026
$3.57
$1.74
-49.71%
Jun 2026
$1.69
$3.46
+60.19%
May 2026
$2.70
$2.16
-25.52%
Apr 2026
$3.11
$2.90
-7.64%
Mar 2026
$3.01
$3.14
-21.30%
Feb 2026
$4.77
$3.99
-37.75%
Jan 2026
$7.00
$6.41
-5.74%
Dec 2025
$7.40
$6.80
N/A

Regentis Share Price FAQs